Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
adverse drug reaction
anaphylaxis
CAT scan, abnormal
cerebral ischemia
cerebrovascular accident
cerebrovascular accident, bilateral
chymopapain
contrast agents, neurotoxicity of
cop 1
diplegia, brachial
fibrinolytic agents, complications
gadolinium
geniculate body, lateral
headache
hypotension, systemic
iatrogenic neurologic disorders
interferon
interferon beta 1-a
Man-In-The-Barrel syndrome
MRI
MRI, abnormal
MRI, complications with
MRI, contrast enhanced
multiple sclerosis, treatment of
nausea and vomiting
rash
steroid therapy, CNS treatment and complications with
symmetric brain lesions
tissue plasminogen activator, intravenous
visual field defect
visual loss
visual loss, sudden
watershed infarcts
Showing articles 1150 to 1200 of 4199 << Previous Next >>

Chronic Granulomatous Herpes Encephalitis: A Rare Entity Posing a Diagnostic Challenge
J Neurosurg Pediatrics 8:402-406, Adamo, M.A.,et al, 2011

Focal Status Epilepticus Induced by Hyperbaric Oxygen Therapy
The Neurologist 17:31-33, Seckin,M.,et al, 2011

Xylometazoline Abuse Induced Ischemic Stroke in a Young Adult
The Neurologist 17:41-43, Leupold,D.,et al, 2011

New Alternative to Warfarin May Help Reduce Stroke Risk in Patients With AF
JAMA 305:25-26, Mitka,M., 2011

A Randomized Trial of Prenatal Versus Postnatal Repair of Myelomeningocele
NEJM 364:993-1004, 1076, Adzick,N.S.,et al, 2011

Delirium in the Acute Phase After Stroke
Neurol 76:993-999, Oldenbeuvig,A.W., et al, 2011

Brucellosis Mimicking Demyelinating Disease
Neurol 76:e51, Abrah�o,et al, 2011

Pediatric Sciatic Neuropathies: A 30-year Prospective Study
Neurol 76:976-979, Srinivasan,J.,et al, 2011

Primary Varicella Zoster Infection Associated With Fingolimod Treatment
Neurol 76:1023-1024, Uccelli,A.,et al, 2011

Apixaban in Patients With Atrial Fibrillation
NEJM 364:806-817, Connolly,S.J.,et al, 2011

Recognizing Guillain-Barr� Syndrome in Preschool Children
Neurol 76:807-810, Roodbol,J.,et al, 2011

Stem Cell Transplantation for Ischemic Stroke
Stroke 42:e33, Boncoraglio,G.B.,et al, 2011

Screening for Fitness to Drive After Stroke: A Systematic Review and Meta-Analysis
Neurol 76:747-756, e35, Devos,H.,et al, 2011

Increasing Incidence of Ischemic Stroke in Patients With HIV Infection
Neurol 76:444-450, Ovbiagele,B. &Nath,A., 2011

Child Development Following In Utero Exposure: Levetiracetam vs Sodium Valproate
Neurol 76:383-389, Shallcross,R.,et al, 2011

Hemicraniectomy in Malignant Middle Cerebral Artery Infarction
Stroke 42:513-516, Staykov,D. &Gupta,R., 2011

Incidence and Predictors of Myocardial Infarction After Transient Ischemic Attack: A Population-Based Study
Stroke 42:935-940, Burns,J.D.,et al, 2011

Bridging Intravenous-Inta-Arterial Rescue Strategy Increases Recanalization and the Likelihood of a Good Outcome in Nonresponder Intravenous Tissue Plasminogen Activator-Treated Patients: A Case-Control Study
Stroke 42:993-997, 880, Rubiera,M.,et al, 2011

Subtherapeutic Warfarin Is Not Associated With Increased Hemorrhage Rates in Ischemic Strokes Treated With Tissue Plasminogen Activator
Stroke 42:1041-1045, Vergouwen,M.D.I.,et al, 2011

Diagnosis and Management of Cerebral Venous Thrombosis: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association
Stroke 42:1158-1192, Saposnik,G.,et al, 2011

HLA-A*3101 and Carbamazepine-Induced Hypersensitivity Reactions in Europeans
NEJM 364:1134-1143, McCormack,M.,et al, 2011

HLA-A*3101 and Carbamazepine-Induced Hypersensitivity Reactions in Europeans
NEJM 364:1126-1133, Chen,P.,et al, 2011

Diagnosing variant Creutzfeldt-Jakob disease: a retrospective analysis of the first 150 cases in the UK
JNNP 82:646-651, Heath, C.A.,et al, 2011

The use of rituximab in myasthenia gravis and Lambert--Eaton myasthenic syndrome
JNNP 82:671-673, Maddison, P.,et al, 2011

Movement Disorders Emergencies Part 1
, Robottom, B.J., et al, 2011

Statin Use Following Intracerebral Hemorrhage
Arch Neurol 68:573-579, Westover, M.B.,et al, 2011

Mechanisms of Fingolimods Efficacy and Adverse Effects in Multiple Sclerosis
Ann Neurol 69:759-777, Cohen, J.A. & Chun, J., 2011

Randomized, double-blind, placebo-controlled trial of ezogabine (retigabine) in partial epilepsy
Neurol 76:1555-1563, French, J.A.,et al, 2011

Dabigatran etexilate versus warfarin as the oral anticoagulant of choice? A review of clinical data
Pharmacol Ther 129:185-194, Terry, K.W.,et al, 2011

Decompressive Craniectomy in Diffuse Traumatic Brain Injury
NJM 364:1493-1502, Cooper, D.J.,et al, 2011

Skin biopsy is useful for the antemortem diagnosis of neuronal intranuclear inclusion disease
Neurol 76:1372-1376, Sone, J.,et al, 2011

Radiculomyelitis due to atypical tuberculous infection: 4 case report
JNNP 82:585-587, Feng, Y.,et al, 2011

Pediatric Neurological Complications of 2009 Pandemic Influenza A (H1N1)
Arch Neurol 68:455-462, Kedia, S.,et al, 2011

Efficacy and Safety of Mitoxantrone in Patients with Highly Relapsing Neuromyelitis Optica
Arch Neurol 68:473-479, Kim, S.H.,et al, 2011

Folic acid supplementation prevents phenytoin-induced gingival overgrowth in children
Neurol 76:1338-1343, Arya, R.,et al, 2011

Prevalence of MRI-defined recent silent ischemia and associated bleeding risk with thrombolysis
Neurol 76:1288-1295, Tisserand, M.,et al, 2011

Oral vs Intratympanic Corticosteroid Therapy for Idiopathic Sudden Sensorineural Hearing Loss
JAMA 305(20):2071-2079,2114, Rauch, S.D.,et al, 2011

Are all IV thrombolysis exclusion criteria necessary? Being SMART about evidence-based medicine
Neurol 76:1780-1781, Tong, D., 2011

Safety and Outcomes of Intravenous Thrombolysis in Stroke Mimics
Stroke 42:1771-1774, Tsivgoulis, G.,et al, 2011

Clinical and MRI characteristics of acute migrainous infarction
Neurol 76:1911-1917, Wolf, M.E.,et al, 2011

Comparison of IVIg and PLEX in patients with myasthenia gravis
Neurol 76:2017-2023, Barth, D.,et al, 2011

Intravenous Thrombolytic Therapy for Acute Ischemic Stroke
NEJM 364:22, Wechsler, L.R., 2011

Lingual Hematoma After Thrombolytic Therapy
NEJM 364:e13, Vijayan,S. &Chase,A., 2011

Tumefactive Demyelination, an Uncommon Form of Tacrolimus Neurotoxicity
Neurol 76:672-674, Kim,S.H.,et al, 2011

Immune Reconstitution Inflammatory Syndrome in Patients With Multiple Sclerosis Following Cessation of Natalizumab Therapy
Arch Neurol 68:186-191, Miravalle,A.,et al, 2011

Deep Brain Stimulation for Parkinson Disease: An Expert Consensus and Review of Key Issues
Arch Neurol 68:165-171, Bronstein,J.M.,et al, 2011

Phase III Dose-Comparison Study of Glatiramer Acetate for Multiple Sclerosis
Ann Neurol 69:75-82, Comi,G.,et al, 2011

Differential Diagnosis of Bilateral Abnormalities of the Basal Ganglia and Thalamus
RadioGraphics 31:5-30, Hegde,A.N.,et al, 2011

Newer-Generation Antiepileptic Drugs and the Risk of Major Birth Defects
JAMA 305:1996-2002, Molgaard, D. & Hviid, A., 2011

Evidence-based guideline: Treatment of painful diabetic neuropathy
Neurol 76:1758-1765, Bril,V., et al, 2011



Showing articles 1150 to 1200 of 4199 << Previous Next >>